Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsLeukemia, MyeloidLeukemia, Myeloid, AcuteLeukemiaGraft vs Host DiseaseTransplantation, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticTransplantation ChimeraLiver TransplantationBusulfanTissue DonorsGraft SurvivalHematopoietic Stem CellsBone Marrow PurgingPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHistocompatibility TestingAcute DiseaseCyclophosphamideRecurrenceHistocompatibilityHematologic NeoplasmsTreatment OutcomeTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisCytarabineCombined Modality TherapyMyelodysplastic SyndromesKidney TransplantationBone Marrow ExaminationMice, Inbred C57BLTime FactorsRadiation ChimeraLeukemia, LymphoidImmunosuppressive AgentsSurvival AnalysisStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsGraft RejectionHepatic Veno-Occlusive DiseaseLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-CellRetrospective StudiesLeukemia, ExperimentalBone Marrow NeoplasmsBone RemodelingLeukocyte TransfusionFusion Proteins, bcr-ablTransplantation ImmunologyGraft vs Host ReactionLymphocyte DepletionT-LymphocytesImmunosuppressionCell DifferentiationColony-Forming Units AssayPrognosisSurvival RateDisease-Free SurvivalHeart TransplantationChimeraHLA AntigensGene Expression Regulation, LeukemicActuarial AnalysisGraft vs Leukemia EffectFlow CytometrySevere Combined ImmunodeficiencyLymphomaFollow-Up StudiesHematologic DiseasesLymphocyte TransfusionCyclosporineAntineoplastic AgentsLeukemia, Myelomonocytic, AcuteEtoposideLeukocyte CountGranulocyte Colony-Stimulating FactorLung TransplantationAntigens, CD34ImmunophenotypingLeukemia, Myeloid, Chronic-PhaseBone DensityDaunorubicinNuclear FamilyPancytopeniaNeoplasm, ResidualBlast CrisisCarmustineKaryotypingGranulocytesGraft vs Tumor EffectFatal Outcome